Related references
Note: Only part of the references are listed.Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data
Lu Wang et al.
GENES CHROMOSOMES & CANCER (2012)
FUS-CREB3L2/L1-Positive Sarcomas Show a Specific Gene Expression Profile with Upregulation of CD24 and FOXL1
Emely Moller et al.
CLINICAL CANCER RESEARCH (2011)
An introduction to the molecular basics of aryl hydrocarbon receptor biology
Josef Abel et al.
BIOLOGICAL CHEMISTRY (2010)
Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli
Yoshiaki Fujii-Kuriyama et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2010)
Genomic characteristics of soft tissue sarcomas
Fredrik Mertens et al.
VIRCHOWS ARCHIV (2010)
Regulation of constitutive and inducible AHR signaling: Complex interactions involving the AHR repressor
Mark E. Hahn et al.
BIOCHEMICAL PHARMACOLOGY (2009)
The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways
Alvaro Puga et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-β Overexpression in the Stroma
Angel Carlos Roman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Active Form of Human Aryl Hydrocarbon Receptor (AHR) Repressor Lacks Exon 8, and Its Pro185 and Ala185 Variants Repress both AHR and Hypoxia-Inducible Factor
Sibel I. Karchner et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Jianming Xu et al.
NATURE REVIEWS CANCER (2009)
ETV6-NCOA2:: A novel fusion gene in acute leukemia associated with coexpression of T-Lymphoid and myeloid markers and frequent NOTCH1 mutations
Sabine Strehl et al.
CLINICAL CANCER RESEARCH (2008)
Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: Role of DNA binding and competition for AHR nuclear translocator
Brad R. Evans et al.
MOLECULAR PHARMACOLOGY (2008)
Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera
Ioannis Panagopoulos et al.
GENES CHROMOSOMES & CANCER (2007)
The impact of translocations and gene fusions on cancer causation
Felix Mitelman et al.
NATURE REVIEWS CANCER (2007)
The inhibitory effect of aryl hydrocarbon receptor repressor (AhRR) on the growth of human breast cancer MCF-7 cells
Yuichiro Kanno et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Richard Smith et al.
CANCER CELL (2006)
A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice
O Moennikes et al.
CANCER RESEARCH (2004)
MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP
K Deguchi et al.
CANCER CELL (2003)
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors
P Andersson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex
TV Beischlag et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
No EWS/FLI1 fusion transcripts in giant-cell tumors of bone
I Panagopoulos et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Structure and expression of the Ah receptor repressor gene
T Baba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymorphism in endometriosis
T Watanabe et al.
JOURNAL OF HUMAN GENETICS (2001)